The round · pre-seed

Not raising to find out whether this works. Raising to go faster.

The hard, slow, uncertain part of this business is building an ontology and a governed engine against a real practice with a real payer mix. That is what the pilot is for, and it is in progress. What money buys is not discovery. It is the two things that are purely a function of capacity: finishing the product faster, and putting clinics onto it faster.

1 dayonboarding target · a claim

A new practice gets its own cloud project, its channels connected, its catchment modelled and its site generated. Not a migration and not a bespoke build — the spoke is provisioned from the same blueprint every time. This is the number the round has to prove at practices that are not the pilot.

At marketpricing · indicative

Priced in line with what a practice already pays an agency to run two channels and nothing else. A dentist is not asked to pay more for something new, but to pay about the same and receive considerably more. Pricing is indicative until the first cohort is signed.

Agent-ledacquisition · a claim

One agent per metro, paid on subscriptions closed and retained. No demand-generation spend, no enterprise cycle, no committee. Acquisition cost scales with headcount rather than with overhead, which is why the constraint is people rather than budget.

Each of those three is a claim, not yet a proven number, and is labelled that way. The pilot is what makes them testable at all: a one-day onboarding is only credible because the spoke is provisioned rather than built, and that is only true because the ontology and the pipelines already exist by the time the second clinic arrives.

What the money does

Two constraints, and money moves both.

Constraint 01 · engineering capacity, against a scope already specified

Product completion

  • Finish the reasoning engine and the dental ontology against the pilot’s live payer mix, so the axiom set covers every segment a general practice bills rather than the subset a narrow clinic would produce.
  • Harden the governance gate to run in front of every generated asset at volume, across FTC, ADA, state board and platform health-content rules.
  • Make spoke provisioning repeatable — the one-day onboarding is an engineering outcome before it is a sales claim.
  • Bring engineering in-house. The first hire the round funds.
Constraint 02 · capacity to sell and to serve, in that order

Clinic onboarding

  • A sales lead and the first territory agents, Houston then the other Texas metros. The motion is run directly first and handed over once it is repeatable.
  • The first cohort of paying practices onto the platform, each one a spoke that adds to the hub whether or not it stays.
  • Instrumented onboarding so time-to-first-value, cost-to-serve and contribution margin per practice are measured from the first clinic rather than reconstructed later.
  • A clinical lead for the medical vertical — a full role built on the emergency-care access already in hand, which is what opens the adjacent vertical rather than a market that merely looks good.

What this round should be able to show at its end

The numbers a seed round should be priced on.

  1. A cohort of paying practices onboarded on the standard blueprint

    To produce

  2. A measured onboarding time

    To produce

  3. A measured cost-to-serve and contribution margin per practice

    To produce

  4. Retention through a renewal

    To produce

Those are the numbers this round exists to produce.

What was heard, and where it came from

The customer problem, in the words of people who have it.

The company is in private alpha, so there is no NPS score to show. What can be shown is the discovery that built the roadmap: structured jobs-to-be-done interviews with practice owners and office managers, run to separate the job a dentist hires marketing to do from the features they ask for. Capabilities that demoed well and failed against the real job were cut.

Practice owner
“I cannot tell you what my marketing did.”

Every owner interviewed pays someone monthly and none could attribute a patient to a channel. They receive a report of impressions and clicks and a bill, and the number that matters — new patients, by payer, at what cost — is not in it. The pilot practice paid for this for three years across multiple agencies before the alternative was built.

Practice owner
“They could sign the practice a mile away tomorrow.”

No dental marketing agency known to Quadfence offers territory exclusivity. An owner is paying a firm that may be running the identical playbook for the practice competing for the same patients. When this came up in interview it produced more reaction than any feature described.

Office manager
“Every change is an email and a wait.”

A photo swap, a page edit, a new offer: an account manager, a queue, sometimes a change order. The people closest to the patient cannot change what the patient sees. That is a production-cost problem, and it is the reason generation sits inside the product rather than beside it.

Practice buyer
“Nobody could tell me if the market was any good.”

The most common anecdote, and the one the product started from. A practice changes hands and the buyer receives verified financials and a page of census demographics. Dentists per capita, household turnover, payer mix on the ground, service gaps — none of it is in the diligence pack, and it is the part that decides whether the practice can grow.

Underneath the interviews sits the structural point: a market this fragmented, served this thinly, is not a market with a satisfied customer in it. The sizing and the comparables are on the market page, with sources and limits on the evidence page.

Investors · the deck and the operating model are available on request Request the deck →